Building up an investment case requires looking at a stock holistically. Today I've chosen to put the spotlight on Handicare Group AB (publ) (STO:HANDI) due to its excellent fundamentals in more than one area. HANDI is a company with an impressive track record of performance, trading at a great value. Below is a brief commentary on these key aspects. If you're interested in understanding beyond my broad commentary, read the full report on Handicare Group here.
Good value with proven track record
In the past couple of years, HANDI has ramped up its bottom line by over 100%, with its latest earnings level surpassing its average level over the last five years. Not only did HANDI outperformed its past performance, its growth also exceeded the Medical Equipment industry expansion, which generated a 17% earnings growth. This is an notable feat for the company. HANDI is currently trading below its true value, which means the market is undervaluing the company's expected cash flow going forward. According to my intrinsic value of the stock, which is driven by analyst consensus forecast of HANDI's earnings, investors now have the opportunity to buy into the stock to reap capital gains. Also, relative to the rest of its peers with similar levels of earnings, HANDI's share price is trading below the group's average. This bolsters the proposition that HANDI's price is currently discounted.
Next Steps:
For Handicare Group, I've compiled three fundamental factors you should further examine:
-
Future Outlook: What are well-informed industry analysts predicting for HANDI’s future growth? Take a look at our free research report of analyst consensus for HANDI’s outlook.
-
Financial Health: Are HANDI’s operations financially sustainable? Balance sheets can be hard to analyze, which is why we’ve done it for you. Check out our financial health checks here.
-
Other Attractive Alternatives : Are there other well-rounded stocks you could be holding instead of HANDI? Explore our interactive list of stocks with large potential to get an idea of what else is out there you may be missing!
We aim to bring you long-term focused research analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.
If you spot an error that warrants correction, please contact the editor at editorial-team@simplywallst.com. This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Simply Wall St has no position in the stocks mentioned. Thank you for reading.